Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P M Ravdin

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Breast Cancer Research and Treatment|March 5, 1999
Time-dependence of hazard ratios for prognostic factors in primary breast cancerS G Hilsenbeck, P M Ravdin, C A de Moor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancerP M Ravdin, L A Siminoff, G J Davis, et al.
Breast Cancer Research and Treatment|January 1, 1992
A demonstration that breast cancer recurrence can be predicted by neural network analysisP M Ravdin, G M Clark, S G Hilsenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomyS G Diab, S G Hilsenbeck, C de Moor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancerP M Ravdin, H A Burris, G Cook, et al.
Cancer Research|December 1, 1991
A phase I clinical and pharmacokinetic trial of hepsulfamP M Ravdin, K A Havlin, M V Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancerP M Ravdin, A K Tandon, D C Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group studyP M Ravdin, S Green, T M Dorr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancerV Valero, S E Jones, D D Von Hoff, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Breast Cancer Research and Treatment|March 5, 1999
Time-dependence of hazard ratios for prognostic factors in primary breast cancerS G Hilsenbeck, P M Ravdin, C A de Moor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 22, 2001
Computer program to assist in making decisions about adjuvant therapy for women with early breast cancerP M Ravdin, L A Siminoff, G J Davis, et al.
Breast Cancer Research and Treatment|January 1, 1992
A demonstration that breast cancer recurrence can be predicted by neural network analysisP M Ravdin, G M Clark, S G Hilsenbeck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 1998
Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomyS G Diab, S G Hilsenbeck, C de Moor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancerP M Ravdin, H A Burris, G Cook, et al.
Cancer Research|December 1, 1991
A phase I clinical and pharmacokinetic trial of hepsulfamP M Ravdin, K A Havlin, M V Marshall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancerP M Ravdin, A K Tandon, D C Allred, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1992
Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group studyP M Ravdin, S Green, T M Dorr, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2005
Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancerS E Jones, J Erban, B Overmoyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 1998
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancerV Valero, S E Jones, D D Von Hoff, et al.
Pageof 6